Your browser doesn't support javascript.
loading
Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cells.
Hanekamp, Diana; Ngai, Lok Lam; Janssen, Jeroen J W M; van de Loosdrecht, Arjan; Ossenkoppele, Gert J; Cloos, Jacqueline.
Afiliação
  • Hanekamp D; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Ngai LL; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Janssen JJWM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • van de Loosdrecht A; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Cloos J; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Blood ; 137(12): 1694-1697, 2021 03 25.
Article em En | MEDLINE | ID: mdl-33171485
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Clofarabina / Antimetabólitos Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Clofarabina / Antimetabólitos Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article